U.S. Orthopedics Makers Shift Production To China
This article was originally published in PharmAsia News
U.S. production of medical devices, long considered unlikely to join the outsourcing move to Southeast Asia, now is migrating to China as firms see it as a good place to make wares. Two orthopedic companies in Indiana already have opened plants in the country and a third has one under construction. The three are Biomet, DePuy Orthopaedics and Paragon Medical. The shift is not just for devices sold in Asia; it also includes production of products for the U.S. market. (Click here for more
You may also be interested in...
The final opinion of ECHA’s Socio-Economic Analysis Committee, published on 1 March, is largely unchanged from its July 2020 draft opinion with regard to microplastic in cosmetic products. That means industry may have to convince EU member state authorities that the restriction proposal has a serious proportionality problem.
Representatives from cardiac monitoring device manufacturers and professional societies are working together to persuade Medicare carrier Novitas to reconsider its payment rates for extended cardiac monitoring. See what Michael Coyle, iRhythm’s CEO, said about it here.
As agency implements testing contract for its staff, sponsors are drawing up protocols to ensure inspector safety and forwarding them to FDA, but still can’t trigger an inspection.